126504-86-7 Usage
Uses
Used in Pharmaceutical Industry:
Pyrimidine, 5-(chloromethyl)-2-methyl(9CI) is used as a building block for the synthesis of various pharmaceuticals. Its reactivity, due to the chloromethyl group, allows for the formation of new carbon-carbon bonds, which is crucial in the development of complex drug molecules.
Used in Agrochemical Industry:
In the agrochemical industry, Pyrimidine, 5-(chloromethyl)-2-methyl(9CI) serves as a starting material for the production of other pyrimidine derivatives with potential biological activities. These derivatives can be used in the development of new agrochemicals, such as pesticides and herbicides, that can help improve crop protection and yield.
Used in Antineoplastic Drug Development:
Pyrimidine, 5-(chloromethyl)-2-methyl(9CI) is used as a starting material in the development of new antineoplastic drugs. Its potential biological activities make it a promising candidate for the creation of novel cancer treatments that could offer improved efficacy and reduced side effects compared to existing therapies.
Used in Antiviral Drug Development:
Pyrimidine, 5-(chloromethyl)-2-methyl(9CI) is also utilized in the development of new antiviral drugs. Its unique structure and reactivity contribute to the design of antiviral agents that can target and inhibit viral replication, offering potential new treatment options for viral infections.
Check Digit Verification of cas no
The CAS Registry Mumber 126504-86-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,5,0 and 4 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 126504-86:
(8*1)+(7*2)+(6*6)+(5*5)+(4*0)+(3*4)+(2*8)+(1*6)=117
117 % 10 = 7
So 126504-86-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H7ClN2/c1-5-8-3-6(2-7)4-9-5/h3-4H,2H2,1H3
126504-86-7Relevant academic research and scientific papers
AZAINDOLES AND METHODS OF USE THEREOF
-
Page/Page column 36; 42, (2019/02/17)
Disclosed are compounds according to Formula (I) or (II), and pharmaceutical compositions comprising them. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (I) or (II). (Formulae (I, (II))
cGAS ANTAGONIST COMPOUNDS
-
Paragraph 0219; 0297; 0314, (2017/11/06)
Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
-
Page/Page column 387, (2014/09/29)
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
-
Paragraph 0311; 0312, (2014/09/30)
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
(2,5)Pyrimidinophanes: Synthesis and Molecular Structure
Eiermann, Uwe,Krieger, Claus,Neugebauer, Franz A.
, p. 1885 - 1889 (2007/10/02)
The title compounds 1 and 2 are synthesized by photolytic sulfur extrusion from 2,11-dithia(2,5)pyrimidinophane 17.The molecular structures of 1 and 2 are determined by X-ray structure analysis and are discussed with regard to the steric strain in these molecules.Thermolysis of - or -trimethylammonium hydroxide (10 or 11) does not generate 1 and 2. α-Chlorination of 2,5-dimethylpyrimidine (3) with N-chlorosuccinimide provides the required precursors 4 - 6.
